Rethinking, comment and query of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults
Hu, D.
Zhonghua xin xue guan bing za zhi 42(1): 3-5
2014
ISSN/ISBN: 0253-3758 PMID: 24680258 Document Number: 673249
Document emailed within 1 workday
Related Documents
Konstantinov, V.O. 2017: The Role of non-Statin Therapy for Lowering the Concentration of low-Density Lipoprotein Cholesterol and Reducing the Risk of Developing Atherosclerotic Cardiovascular Complications Kardiologiia 57(5): 68-72Zhao, S.; Peng, D.; Yu, B.; Huang, X.; Hu, D.; Shi, X. 2014: New thought from American new guideline on the treatment of blood cholesterol Zhonghua xin xue guan bing za zhi 42(2): 123-125
Jee, S.H.; Suh, I.; Kim, I.S.; Appel, L.J. 1999: Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study JAMA 282(22): 2149-2155
Lipshultz, S.E.; Schaechter, J.; Carrillo, A.; Sanchez, J.; Qureshi, M.Yasir.; Messiah, S.E.; Hershorin, E.R.; Wilkinson, J.D.; Miller, T.L. 2012: Can the consequences of universal cholesterol screening during childhood prevent cardiovascular disease and thus reduce long-term health care costs? Pediatric Endocrinology Reviews: Per 9(4): 698-705
Kalinina, A.M.; Chazova, L.V.; Perova, N.V.; Pavlova, L.I.; Shchepkin, V.V. 1993: An increased risk of death from ischemic heart disease in men with low blood concentrations of total cholesterol and low-density lipoprotein cholesterol Terapevticheskii Arkhiv 65(4): 27-32
Zhang, Y. 2002: Further recognize the benefit and risk of postmenopausal hormone replacement therapy on atherosclerotic cardiovascular diseases Zhonghua Fu Chan Ke Za Zhi 37(6): 321-323
Arnaiz, P.; Pino, F.; Marín, A.; Barja, S.; Aglony, M.; Cassis, B.; Navarrete, C.; Acevedo, Mónica. 2010: Association between a cardiovascular risk score and early markers of atherosclerotic disease in Chilean children Revista Medica de Chile 138(10): 1226-1231
Dörpinghaus, S.; Schröter, B. 2005: Changes in education: new guideline ideas require rethinking Pflege Zeitschrift 58(1): 29-32
Durak, I.; Oztürk, H.Serdar.; Olcay, E.; Güven, C. 2002: Effects of garlic extract supplementation on blood lipid and antioxidant parameters and atherosclerotic plaque formation process in cholesterol-fed rabbits Journal of Herbal PharmacoTherapy 2(2): 19-32
Cariou, B. 2016: Cardiovascular risk: what is the role of HDL cholesterol? La Revue du Praticien 66(3): 330-331
Simon, K.; Kowalewski, W.; Dobracki, W. 1987: Evaluation of the indicators of arteriosclerosis risk factors: cholesterol:HDL cholesterol and LDL cholesterol: HDL cholesterol in acute and chronic diseases of the liver Przeglad Lekarski 44(11): 746-750
Mittal, M.; Fay, W.P. 2013: Almost everyone over 50 should be put on a statin to reduce the risk of cardiovascular disease: a contrarian view Missouri Medicine 110(4): 339-341
Washington, R.L. 1999: Interventions to reduce cardiovascular risk factors in children and adolescents American Family Physician 59(8): 2211-2218
Kannel, W.B. 1996: Blood pressure as a cardiovascular risk factor: prevention and treatment JAMA 275(20): 1571-1576
Berchtold, P.; Berger, M.; Jörgens, V.; Daweke, C.; Chantelau, E.; Gries, F.A.; Zimmermann, H. 1981: Cardiovascular risk factors and HDL-cholesterol levels in obesity International Journal of Obesity 5(1): 1-10
Suntornpong, N.; Sukkasem, M.; Uwattanasombat, C.; Samasanti, N.; Thephamongkol, K. 2011: The effectiveness of clinical practice guideline for nasopharyngeal and oropharyngeal cancer to reduce acute treatment toxicity from concurrent chemoradiation Journal of the Medical Association of Thailand 94(5): 585-591
Horibe, H. 1991: Serum cholesterol levels as a risk factor of cardiovascular disease Rinsho Byori. Japanese Journal of Clinical Pathology 39(5): 501-505
Zelissen, P.M.J.; Mathus-Vliegen, E.M.H. 2004: Treatment of overweight and obesity in adults: proposal for a guideline Nederlands Tijdschrift Voor Geneeskunde 148(42): 2060-2066
Ebell, M.H. 2017: In Patients with Vascular Disease, Treating Sleep Apnea Does Not Reduce the Risk of Cardiovascular Events American Family Physician 95(2): 123-123
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558